Collagen Dressings Market Segmentation:
Application Segment Analysis
Based on application, the chronic wounds segment is expected to garner the highest share of 65.6% in the collagen dressings market by the end of 2037. The dominance of the segment is effectively attributed to the increasing instances of diabetic foot and the longer recovery periods. In this context, NIH states that diabetic foot ulcers affect 25.7% of diabetic patients across the world, and they account for 42% of chronic wound cases that require collagen dressings. Besides, the venous leg ulcers and pressure ulcers drive 52.3% of collagen dressing demand among geriatric demographics, thus denoting a wider segment adoption.
Product Type Segment Analysis
In terms of product type, the antimicrobial collagen dressings segment is projected to grow at a considerable rate, with a share of 32.4% during the assessed timeframe. The growth in the segment is subject to the presence of surgical site infections (SSIs) and antibiotic resistance. In this regard, the CDC report states that 2.5% of all surgical procedures performed in the U.S. result in SSIs, thereby leading to increased treatment expenditure. Simultaneously, the WHO estimates that antimicrobial resistance can lead to 10 million yearly deaths by 2050 if not addressed well. Therefore, this is the evidence for a positive segment demand inspiring firms to invest in this sector.
Our in-depth analysis of the global market includes the following segments
| Segment |
Subsegment |
|
Product Type |
|
|
Application |
|
|
End User |
|
